GSK Says Long-Acting HIV Prevention Drug 65% More Effective Than Truvada GSK Says Long-Acting HIV Prevention Drug 65% More Effective Than Truvada

Britain ' s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 65% more effective in preventing HIV infections than Gilead ' s Truvada daily oral pills.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news